Role of Ivabradine for Heart Rate Control in Management of Patients With Sepsis and Septic Shock

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

Heart Rhythm Disorder

Interventions

DRUG

Ivabradine 5mg Tab

Ivabradine (5 mg twice daily) orally or via nasogastric tube

DRUG

control

Patients didn't receive Ivabradine .

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT06742164 - Role of Ivabradine for Heart Rate Control in Management of Patients With Sepsis and Septic Shock | Biotech Hunter | Biotech Hunter